职称：

教授、主任医师

研究工作：

创建中国肺功能联盟并任总负责人，组织制定了我国肺功能检查系列指南，倡导“像量血压一样检查肺功能”，并组织了“肺功能检查规范化培训万里行”等系列活动，覆盖全国2千多家医院，规培医师1万多名，积极推动我国肺功能临床应用

研究方向：

慢性气道疾病（慢性阻塞性肺疾病、支气管哮喘等）诊治、肺功能检查、呼吸药物临床研究、呼吸大数据分析。

科研项目：

1、国家重点研发计划—重大慢病专项：呼吸系统疾病临床研究大数据与生物样本库平台（2018YFC1311900）

2、国家科技支撑计划—慢性阻塞性气道疾病肺功能检查规范化临床应用体系建设与推广(2015BAI12B10)

3、国家自然科学基金—慢性阻塞性肺疾病发病中粘蛋白MUC5B的作用机制及羧甲司坦干预研究（81470234）

代表性学术论文：

1、Jinfang Ma, Jinping Zheng*, Nanshan Zhong*. Effects of YuPingFeng granules on acute exacerbations of chronic obstructive pulmonary disease: a randomized, placebo-controlled study. 2018,13 :3107–3114

2、Chen CL, ..., Jinping Zheng*. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness. International Journal of COPD 2016:11 2519–2526

3、Jinping Zheng*, Nanshan Zhong*, Amy Newlands, Alison Church, Aik H Goh. Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo controlled study. International Journal of COPD 2015:10 1753–1767

4、Wang Wei, Zheng Jin-ping*, Zhu Shao-xuan, GuanWei-jie, Chen Mao, Zhong Nan-shan*. Carbocisteine attenuates hydrogen peroxide-induced inflammatory injury in A549 cells via NF-κB and ERK1/2 MAPK pathways. International Immunopharmacology 2015;24: 306-313

5、Jinping Zheng, Teresita de Guia, Jie Wang-Jairaj, Amy H. Newlands, Changzheng Wang, Courtney Crim, Triangle Park, Nanshan Zhong*. Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Current Medical Research & Opinion 2015;31(6):1191–1200

6、Jin-Ping Zheng, Fu-Qiang Wen, Chun-Xue Bai, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med, 2014;2: 187-94

7、Jinping Zheng, Jinghua Yang, Xiangdong Zhou, et al. Roflumilast for the treatment of COPD in an Asian population - a randomized double-blind, parallel-group study. Chest, 2014;145(1):44–52.

8、Weijie Guan, Jinping Zheng*, Yi Gao, et al. Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene -responsiveness subtypes. J Allergic Clin Immunol 2013; 131:332-8

9、Zhu Z, Zheng JP*, et al. Questionnaire survey on clinical application of aerosol nebulization therapy in China. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2014

10、Nanshan Zhong, Jinping Zheng*, et al. Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease. Current Medical Research & Opinion 2012；28（2）：1–9

11、Zheng JP, et al. Preventive Effect on Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) with Carbocisteine (PEACE Study): A Randomized Placebo Controlled study. Lancet 2008; 372: 1631-1632

12、Zheng JP, Yang L, Bai CX, et al. The efficacy and safety of combination salmeterol (50 μg) / fluticasone propionate (500 μg) inhalation twice daily via Accuhalar in Chinese patients with COPD. Chest, 2007;132(6):1756-63

13、郑劲平*、高怡*。肺功能检查指南：第一部分-概述及一般要求。中华结核和呼吸杂志。2014 ；37（6）：402-5

14、周明娟*、郑劲平* 肺功能检查指南——肺弥散功能检查 中华结核和呼吸杂志 2015；38（3）：164-9

15、江梅，郑劲平*.慢阻肺临床试验常用评价指标及相关统计分析方法的应用。中华医学杂志2018;98(4):309-312.

16、国家呼吸系统疾病临床医学研究中心,国家食品药品监督管理总局药品审评中心（郑劲平*）.慢性阻塞性肺疾病药物临床试验规范[J].中华医学杂志,2018,98(4):248-259.

获奖及个人荣誉：

1、获国家科技进步二等奖2项

2、省部级科技进步一等奖3项

3、药明康德生命化学奖

4、国务院政府特殊津贴专家

5、国家卫计委突出贡献中青年专家

6、中国优秀呼吸医师

7、广州市优秀专家

8、广州市优秀教师、

9、羊城好医生

联系方式：

Email: jpzhenggy@163.com